Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-21

Clinical Trial Update: A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment. [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating the effects and safety of a combination of fluticasone furoate and GW642444M in healthy subjects and in individuals with va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Furoate (fluticasone furoate)
  • GW642444M (GW642444M)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED